Drug
Kpl 404
Kpl 404: highest development phase Phase 2, developed by Kiniksa Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kiniksa Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| KPL-404 NCT05198310 | Phase 2 | Arthritis, Rheumatoid |
| KPL-404 NCT04497662 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Kpl 404 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.